Pharmacology Exam 2: Antibacterials, Antivirals, Antifungals, and Administration

Vocabulary practice flashcards covering core pharmacology concepts, antimicrobials, antivirals, antituberculars, antifungals, injection angles, and nursing safety principles for Exam 2.

Empiric Therapy

Antimicrobial therapy initiated before a definite diagnosis or pathogen identification is confirmed; typically broad-spectrum in nature (e.g., starting an antibiotic prior to the return of culture and sensitivity results).

Prophylactic Therapy

Medication administered to prevent infection before potential microbial exposure, such as prior to dental or invasive surgical procedures, or as tuberculosis prevention in latent infections.

Therapeutic Therapy

Antimicrobial treatment directed against a known, identified pathogen, optimally selected after culture and sensitivity ($\text{C\&S}$) results are finalized.

Bactericidal

An antibacterial agent or action that directly kills bacteria; often associated with more significant side effects compared to bacteriostatic agents.

Bacteriostatic

An antibacterial agent or action that slows or halts bacterial growth and replication without directly destroying the organism; typically less harmful to host tissues.

Inherent Resistance

Natural, baseline bacterial resistance in which an organism is inherently unaffected by a particular drug without previous exposure.

Acquired Resistance

Resistance that develops in previously susceptible bacteria after drug exposure, driven by repeated or inappropriate use, dose skipping, incomplete regimens, or hospital-acquired infections.

Cross-Resistance

A phenomenon where bacterial resistance developed against one antibacterial agent extends to other drugs possessing a similar mechanism of action or chemical structure (e.g., between penicillins and cephalosporins).

Culture and Sensitivity (C&S)

A diagnostic laboratory test where the culture isolates and identifies the specific pathogen, and sensitivity testing determines which antimicrobial agents will inhibit or destroy it; must be collected before administering the first dose of an antibiotic.

Additive Effect

A drug combination interaction where the cumulative pharmacological response is doubled or equal to the simple sum of both individual agents.

Synergistic / Potentiative Effect

A drug interaction occurring when one medication potentiates or enhances the therapeutic action of another, producing an overall effect greater than the sum of each drug given alone.

Antagonistic Combination

A drug pairing in which one agent reduces or cancels the desired clinical effect of another, such as concurrently combining a bactericidal drug with a bacteriostatic drug.

Paradoxical Effect

An unexpected, contradictory drug reaction that produces the opposite effect of what is typically intended or anticipated.

Superinfection

A secondary opportunistic infection occurring when antimicrobial therapy eradicates normal host flora, permitting resistant organisms (such as $Candida$ or $Clostridium\ difficile$) to proliferate.

Penicillinase

A specific bacterial beta-lactamase enzyme produced by pathogens (such as $Staphylococcus\ aureus$) that cleaves the beta-lactam ring of penicillin G, rendering the antibiotic ineffective.

Beta-Lactamase Inhibitor Combinations

Formulations combining a beta-lactamase inhibitor (e.g., clavulanate, sulbactam, tazobactam) with a penicillinase-sensitive penicillin (e.g., Augmentin, Unasyn, Zosyn); the inhibitor is never administered alone and protects the antibiotic from enzymatic degradation.

Basic Penicillins (Penicillin G and Penicillin V)

Narrow-spectrum, Pregnancy Category B beta-lactam antibiotics effective primarily against gram-positive organisms; Pen G requires deep Z-track IM administration due to injection-site pain, whereas Pen V is administered orally and contains potassium.

Penicillinase-Resistant Penicillins

Narrow-spectrum anti-staphylococcal penicillins (e.g., dicloxacillin, nafcillin, oxacillin) designed specifically to treat penicillinase-producing $Staphylococcus\ aureus$ infections such as bacteremia, endocarditis, and meningitis.

Stevens-Johnson Syndrome

A severe, life-threatening hypersensitivity reaction characterized by erythematous skin lesions progressing to widespread epidermal peeling and sloughing; classically associated with amoxicillin and fluoroquinolones.

Cephalosporins

A major class of bactericidal beta-lactam antibiotics that inhibit cell wall synthesis; extensively utilized for surgical prophylaxis, with succeeding generations demonstrating broader gram-negative coverage and enhanced beta-lactamase stability.

Fifth-Generation Cephalosporins

The newest group of cephalosporins, distinct for being the first in their class clinically active against resistant gram-positive organisms including MRSA, VRSA, and VISA.

Macrolides

Broad-spectrum antibiotics (such as erythromycin and azithromycin) that bind to the $50\text{S}$ ribosomal subunit to inhibit bacterial protein synthesis; bacteriostatic at low-to-moderate doses and bactericidal at elevated concentrations.

Azithromycin (Zithromax)

A macrolide antibiotic with an exceptionally long half-life ($68\text{ hours}$) permitting once-daily dosing across a $5\text{-day}$ regimen; excreted primarily via bile (requiring intact hepatic function) and subject to decreased absorption if taken with antacids.

Clindamycin

A narrow-spectrum lincosamide antibiotic active against gram-positive organisms and anaerobes; commonly selected for patients allergic to penicillin, incompatible with seizure medications, and strongly linked to $Clostridium\ difficile$-associated diarrhea.

Vancomycin

A bactericidal glycopeptide antibiotic that inhibits cell wall synthesis; used for severe MRSA and cardiac surgery prophylaxis, requiring routine serum peak and trough monitoring due to ototoxic and nephrotoxic profiles.

Red Man Syndrome

A toxic, non-allergic infusion reaction triggered by rapid intravenous administration of vancomycin; manifested by profound hypotension, tachycardia, and prominent flushing/erythema of the face, neck, and upper torso.

Tetracyclines

Broad-spectrum, bacteriostatic antibiotics inhibiting bacterial protein synthesis; strictly contraindicated in pregnant women and children under $8\text{ years}$ of age due to permanent enamel discoloration of developing teeth.

Doxycycline

A tetracycline derivative that can be taken with food to reduce GI upset; requires patient education regarding photosensitivity (sunblock use) and copious fluid intake to maintain light-yellow urine for renal elimination.

Gentamicin

A bactericidal aminoglycoside targeting aerobic gram-negative bacilli (e.g., $Pseudomonas$, $Proteus$, $E.\ coli$); requires peak and trough drug monitoring and carries severe risks of irreversible ototoxicity and nephrotoxicity.

Fluoroquinolones

Bactericidal antibiotics (e.g., levofloxacin, ciprofloxacin) that inhibit bacterial DNA gyrase; notable for signature adverse risks of tendon rupture, exacerbation of myasthenia gravis, insomnia, and photosensitivity.

Sulfonamides (TMP-SMX / Bactrim)

Bacteriostatic antimicrobials that block bacterial folic acid synthesis; frequently prescribed for UTIs, with nursing considerations including checking baseline CBCs, pushing fluids, and monitoring for painless hematuria or crystalluria.

Metronidazole (Flagyl)

A synthetic antimicrobial and antiprotozoal agent used for amebiasis, trichomoniasis, bacterial vaginosis, and colorectal surgical prophylaxis; requires total alcohol abstinence during and for $48\text{ hours}$ after therapy to prevent disulfiram-like reactions.

Isoniazid (INH)

A first-line antitubercular agent (Pregnancy Category C) that inhibits tubercle cell wall synthesis; requires strict alcohol avoidance, frequent LFT monitoring, and co-administration of pyridoxine ($\text{vitamin B}_6$) to prevent peripheral neuropathy.

Rifampin

A cornerstone first-line antitubercular drug that uniquely turns bodily secretions (urine, sweat, tears) a harmless red-orange color, can permanently stain soft contact lenses, and necessitates monitoring of liver enzymes and WBC counts.

Fluconazole

An azole antifungal (Pregnancy Category C) effective against systemic and superficial $Candida$; significantly prolongs PT/INR when combined with warfarin and potentiates hypoglycemia with oral sulfonylureas.

Nystatin

A polyene antifungal agent utilized topically or orally for superficial candidal overgrowth (oral thrush), with "swish and swallow" being the primary clinical administration method.

Acyclovir

A Pregnancy Category B synthetic purine nucleoside antiviral that inhibits viral DNA synthesis in HSV-1 and HSV-2; carries potential risks of nephrotoxicity, neurotoxicity, bone marrow depression, and gingival hyperplasia.

Oseltamivir (Tamiflu)

An oral neuraminidase inhibitor indicated for the treatment of uncomplicated acute influenza; must be initiated within $48\text{ hours}$ of symptom onset and warrants close monitoring for delirium, abnormal behavior, and self-injury.

Human Immunodeficiency Virus (HIV)

An RNA retrovirus that infects and progressively depletes host $\text{CD4}^+\text{ T}$ lymphocytes (normal range: $500\text{--}1200\text{ cells/mm}^3$), predisposing untreated individuals to severe opportunistic infections and neoplasms.

Antiretroviral Therapy (ART / HAART)

Standard combination drug therapy for HIV management aimed at maximally suppressing viral load, preserving immune function, reducing HIV-related mortality, and preventing disease transmission.

Zidovudine (AZT / Retrovir)

A nucleoside reverse transcriptase inhibitor (NRTI) that prevents maternal-fetal HIV transmission; adverse effects include dose-limiting bone marrow suppression (anemia, neutropenia), lactic acidosis, and bluish-brown fingernail banding.

Efavirenz (Sustiva)

A first-choice non-nucleoside reverse transcriptase inhibitor (NNRTI) that readily crosses the blood-brain barrier into cerebrospinal fluid ($\text{CSF}$), precipitating central nervous system effects such as dizziness, confusion, psychosis, and vivid dreams.

Post-Exposure Prophylaxis (PEP)

An emergency short-course regimen of antiretroviral medications (typically two drugs) started within hours following occupational or non-occupational exposure to HIV and maintained for $4\text{ weeks}$.

Pre-Exposure Prophylaxis (PrEP)

A proactive medication regimen taken continuously by HIV-negative individuals at high risk for acquiring HIV; requires documented negative HIV antibody testing prior to initiation and periodic hepatic monitoring.

Immune Globulin (Gamma Globulin / IgG)

A sterile antibody preparation administered IM or IV that confers passive immunity against viral pathogens (such as Hepatitis B) by blocking cellular viral penetration during early infectious exposure.

Chloroquine

An antimalarial compound targeting $Plasmodium$ species; toxic or fatal in pediatric accidental ingestion, with therapeutic monitoring focused on renal function, cardiovascular effects, and cranial nerve VIII (auditory) toxicity.

Peak Drug Level

The highest circulating concentration of a drug in the bloodstream, typically drawn approximately $30\text{ minutes}$ following the completion of an intravenous infusion.

Trough Drug Level

The lowest therapeutic concentration of a drug in systemic circulation, drawn immediately (minutes) prior to the next scheduled dose to safeguard against drug accumulation and toxicity.

Side Effect

A predictable, secondary physiological response to a medication occurring at typical therapeutic dosages; generally anticipated, mild, and non-emergent (e.g., light nausea, drowsiness).

Adverse Effect

An unintended, undesirable, and potentially life-threatening or harmful reaction to a medication at normal therapeutic doses that may necessitate discontinuing the drug or initiating urgent medical intervention.

Teach-Back Method

A patient education and validation technique in which the clinician asks the patient to explain instructions, schedules, restrictions, or inhalation techniques back in their own words to confirm comprehensive understanding.

Z-Track Technique

A specialized intramuscular injection method that prevents seepage of irritating substances (such as concentrated Penicillin G, iron, or oily steroids) into sensitive subcutaneous adipose tissues.

Intradermal Injection Angle

A needle insertion angle of $10\text{--}15^\bullet$ directly below the epidermis, utilizing a $1\text{ mL}$ syringe to produce a visible cutaneous bleb or wheal.

Subcutaneous Injection Angle

A needle insertion angle of $90^\bullet$ (or $45^\bullet$ for pediatric clients or individuals presenting with minimal subcutaneous adipose tissue) to deliver medication into fatty connective tissue.

Intramuscular Injection Angle

A perpendicular $90^\bullet$ needle insertion angle directly into deep muscular tissue (utilizing the ventrogluteal or deltoid muscles in adults and the vastus lateralis in infants).

Medications That Cross the Blood-Brain Barrier (BBB)

Specific antimicrobial and antiviral agents that penetrate into the cerebrospinal fluid ($\text{CSF}$): Penicillin G (indicated for meningitis and syphilis), third-generation cephalosporins (such as ceftriaxone / Rocephin for meningeal infections), zidovudine (AZT; crosses both the blood-brain barrier and the placenta), and efavirenz (Sustiva; readily crosses into the $\text{CSF}$, causing central nervous system effects like dizziness, confusion, and vivid dreams).

Administering Medication in Children

Clinical practices and precautions for pediatric medication administration:

• Oral Administration: Safest when given via syringe; thicker suspensions are preferred over thin liquids to minimize aspiration risk.
• Injection Angles & Sites: Subcutaneous injections are given at a $45^\circ$ angle in pediatric clients or those lacking adipose tissue. The vastus lateralis is the preferred intramuscular ($\text{IM}$) site for infants.
• Ear Drops: Pull the pinna down and back (unlike adults, which is up and back).
• Dosage: Always weight-based in kilograms ($\text{kg}$); verify current weight before every dose.
• Key Drug Cautions: Tetracyclines are contraindicated under age $8$ (tooth enamel staining); chloroquine carries fatal toxicity risks; fluoroquinolones and acyclovir require strict pediatric caution.
• Developmental Considerations: Children are a vulnerable population requiring parental consent; anticipate fears such as stranger anxiety, bodily mutilation, or viewing illness as punishment.

Physiologic Changes in Older Adults Affecting Pharmacokinetics

Age-related physiological alterations influencing drug processing:

• Absorption: Reduced gastric blood flow, delayed gastric emptying, and dehydration decrease drug absorption.
• Distribution: Decreased lean muscle mass and water with increased body fat; decreased serum albumin results in fewer protein-binding sites, causing higher concentrations of free (active) drug and heightened toxicity risk.
• Metabolism: Decreased hepatic blood flow and liver mass diminish drug clearance, prolonging drug half-lives.
• Excretion: Reduced glomerular filtration rate ($\text{GFR}$) and creatinine clearance impair renal elimination, necessitating reduced dosages (particularly for aminoglycosides).
• Opioid Caution: Heightened susceptibility to severe respiratory depression, hypotension, and reduced cardiac output.

Rifampin: Patient Education

Key teaching points and nursing considerations for this first-line antitubercular agent:

• Bodily Secretion Discoloration: Harmlessly stains urine, sweat, saliva, and tears a red-orange color; permanently ruins soft contact lenses.
• Laboratory Monitoring: Requires periodic monitoring of liver function tests (LFTs) due to hepatotoxicity risks, as well as complete blood counts (WBC count is monitored to evaluate therapeutic response).
• Adherence: Must complete the full multi-drug regimen ($6\text{--}9\text{ months}$) without skipping doses to prevent multi-drug resistant tuberculosis ($\text{MDR-TB}$).

Trimethoprim-Sulfamethoxazole (TMP-SMX): Indications and Side Effects

Clinical indications and adverse effects of this bacteriostatic folate-synthesis inhibitor:

• Indications: Uncomplicated urinary tract infections (UTIs) caused by $\textit{E. coli}$, $\textit{Proteus}$, and $\textit{Klebsiella}$; also used for otitis media, respiratory infections, shigellosis, toxoplasmosis, and MRSA.
• Adverse & Side Effects: Painless hematuria, crystalluria, hypersensitivity reactions, temporary oligospermia (reduced sperm count), and blood dyscrasias (severe neutropenia risk when co-administered with zidovudine).

Gentamicin: Precautions and Nursing Interventions

Safety parameters and nursing care for this bactericidal aminoglycoside:

• Contraindications & Precautions: Contraindicated in severe renal disease, pregnancy (Category C), and breastfeeding; caution in neonates, older adults, and heart failure (delayed excretion).
• Drug Interactions: Co-administration with loop diuretics (furosemide) increases ototoxicity risk; co-administration with vancomycin potentiates nephrotoxicity.
• Nursing Interventions: Obtain culture and sensitivity ($\text{C\&S}$) before the first dose; assess hearing acuity (cranial nerve VIII) and renal labs (BUN, creatinine); monitor therapeutic peak and trough serum drug levels; push fluids unless contraindicated; assess for palpitations and superinfections.

Penicillin as a Prototype: Beta-Lactam Structure

Structural characteristics and pharmacological significance:

• Prototype Role: The first and foundational beta-lactam bactericidal antibiotic that inhibits bacterial cell wall synthesis.
• Beta-Lactam Ring: The core chemical structure shared between penicillins and cephalosporins; accounts for cross-allergenicity (clients allergic to cephalosporins must not receive penicillins without clarifying the order).
• Bacterial Degradation: Bacterial beta-lactamase (penicillinase) cleaves this ring, conferring resistance.
• Inhibitor Combinations: Protected from enzymatic inactivation by combining with beta-lactamase inhibitors (e.g., clavulanate, sulbactam, tazobactam), which cannot be administered alone.

Drugs That Cross the CNS (Blood-Brain Barrier)

Antimicrobial and antiviral agents capable of penetrating into cerebrospinal fluid ($\text{CSF}$):

• Penicillin G: Crosses into the $\text{CSF}$ to treat neurosyphilis and meningitis.
• Third-Generation Cephalosporins: Agents such as ceftriaxone (Rocephin) achieve therapeutic $\text{CSF}$ concentrations for bacterial meningitis.
• Zidovudine (AZT): Penetrates the blood-brain barrier as well as the placenta.
• Efavirenz (Sustiva): Readily enters the $\text{CSF}$, precipitating signature central nervous system effects (psychosis, confusion, vivid dreams, hallucinations, and seizures).

Tetracycline: Nursing Interventions and Patient Education

Clinical guidelines and patient instructions for broad-spectrum tetracyclines:

• Contraindications: Strictly contraindicated in pregnant women and children under $8\text{ years}$ of age due to permanent yellow-brown discoloration of tooth enamel and bone growth impairment.
• Hydration: Drink copious fluids until urine is very light yellow or straw-colored to promote renal clearance and minimize toxic concentration.
• Education: Apply sunblock and wear protective clothing to manage photosensitivity; finish the full regimen; avoid concurrent dairy, calcium, iron, or antacids (diminished absorption); wear gloves during topical application.

Acyclovir: Nursing Interventions and Patient Education

Care considerations for this purine nucleoside antiviral (Pregnancy Category B):

• Indications: Treats Herpes Simplex Viruses (HSV-1, HSV-2) by inhibiting viral DNA synthesis.
• Interventions: Monitor renal function (BUN, creatinine), fluid/electrolyte balance, and complete blood counts (risk of leukopenia and thrombocytopenia); avoid combining with nephrotoxic aminoglycosides.
• Patient Education: Initiate therapy as early as possible (within $24\text{ hours}$ of lesion outbreak) for maximal efficacy; report seizures, tremors, or unusual bruising/bleeding; medication is excreted in breast milk and urine.

Antifungal Medications: Considerations with Laboratory Testing

Laboratory monitoring requirements for systemic antifungal therapy (e.g., fluconazole):

• Hepatic & Renal Panels: Baseline and ongoing liver function tests (LFTs) and renal markers (BUN, creatinine) are critical, as systemic antifungals are contraindicated in severe liver or renal failure.
• Coagulation Studies: When prescribed alongside warfarin, fluconazole increases prothrombin time ($\text{PT/INR}$), necessitating frequent INR testing to avoid hemorrhage.
• Glucose Monitoring: Potentiates hypoglycemia in patients taking oral sulfonylureas, requiring close blood glucose checks.
• Cardiac Warning: Concurrent macrolides (erythromycin) and azoles heighten the risk of fatal ventricular arrhythmias.

Cross-Resistance vs. Acquired Bacterial Resistance

Differentiating clinical bacterial resistance types:

• Cross-Resistance: A phenomenon where bacterial resistance developed against one antibacterial drug extends to other drugs possessing a similar chemical structure or mechanism of action (e.g., between penicillins and cephalosporins).
• Acquired Resistance: Occurs when a previously susceptible bacterial population becomes resistant following drug exposure, driven by improper clinical use, missed doses, incomplete regimens, or healthcare-associated infections ($\text{HAIs}$).
• (Inherent Resistance: Baseline natural insensitivity of an organism without prior drug exposure).

Narrow-Spectrum vs. Broad-Spectrum Antibiotics

Comparison of antibacterial activity ranges:

• Narrow-Spectrum: Selectively effective against a specific group of microorganisms (e.g., basic penicillins and clindamycin targeting primarily gram-positive bacteria); preserves the host normal flora and carries a lower superinfection risk.
• Broad-Spectrum: Effective against a wide array of both gram-positive and gram-negative organisms (e.g., tetracyclines, third-generation cephalosporins); used empirically when the offending pathogen is unidentified, but significantly increases the risk of opportunistic superinfections.

Penicillin G Procaine: Normal Appearance

Physical appearance and administration constraints:

• Appearance: Formulated as an intramuscular-only aqueous suspension that is normally milky white and cloudy.
• Clinical Considerations: The cloudy appearance is an expected characteristic and does not indicate precipitation or spoilage; this formulation is strictly contraindicated for intravenous ($\text{IV}$) administration.
• Technique: Highly painful upon injection; requires deep intramuscular administration via the Z-track technique.

Azithromycin: Rationale for Combination Regimens

Pharmacological reasons for combining this macrolide in multi-drug regimens:

• Broader Coverage: Expands the antimicrobial spectrum across mixed pathogens in complex polymicrobial infections.
• Synergistic Action: Produces an enhanced, potentiative bactericidal response compared to monotherapy.
• Resistance Prevention: Delays or prevents the emergence of resistant microbial strains.
• Pharmacokinetics: Notable for a very long half-life ($68\text{ hours}$), permitting a convenient once-daily, $5\text{-day}$ dosing course.

Doxycycline: Administration with Food

Dietary guidelines and administration rules for this tetracycline derivative:

• Food Intake: Can be administered with food or meals to alleviate gastrointestinal upset (one of the few tetracyclines that allows co-ingestion with meals).
• Restrictions: Must avoid concurrent consumption of dairy products (milk, yogurt), calcium-rich foods, iron supplements, and antacids, as multivalent cations chelate the drug and severely impede absorption.
• Hydration: Maintain copious fluid intake until urine is very light yellow to promote renal excretion.

Ampicillin and Gentamicin: Concurrent Administration Considerations

Administration rules when penicillins and aminoglycosides are ordered concurrently:

• Synergy vs. Inactivation: While therapeutically synergistic in vivo (penicillin breaches the bacterial wall to aid aminoglycoside penetration), penicillins chemically inactivate aminoglycosides if mixed directly.
• Nursing Actions: Never infuse or mix together in the same intravenous bag, syringe, or tubing; administer via separate IV lines or thoroughly flush the tubing between infusions.
• Monitoring: Consistently monitor peak and trough levels, hearing, and renal function.

Sulfonamides: Nursing Interventions and Patient Education

Clinical responsibilities when managing sulfonamide therapy (e.g., Bactrim):

• Interventions: Check baseline and ongoing complete blood count ($\text{CBC}$) to identify blood dyscrasias; monitor renal function (BUN, creatinine) and evaluate for sulfa hypersensitivity.
• Patient Education: Maintain liberal fluid intake (take with a full glass of water, $\ge 2\text{--}3\,\text{L/day}$) to prevent crystalluria; report painless hematuria promptly; wear sunblock and protective clothing for photosensitivity; advise male clients of possible reversible reduction in sperm count.

Ethambutol and Isoniazid (INH): Indications and Education

Indications and clinical teaching for these first-line antitubercular medications:

• Indications: Prescribed in combination regimens to treat active tuberculosis ($\text{TB}$); INH is also prescribed as monotherapy for latent TB prophylaxis.
• Isoniazid (INH) Education: Absolute avoidance of alcohol to avoid severe hepatotoxicity (monitor LFTs); take pyridoxine ($\text{vitamin B}_6$) to prevent peripheral neuropathy; avoid aluminum-based antacids.
• Ethambutol Education: Instruct patients to immediately report changes in visual acuity or red-green color discrimination (optic neuritis); schedule regular baseline and periodic ophthalmic examinations.

Nystatin Suspension: Patient Education

Administration instructions for oral candidal overgrowth (thrush):

• Technique: Prescribed as "swish and swallow"; instruct the patient to shake the suspension thoroughly, swish the solution throughout the mouth to coat all mucosal surfaces for several minutes, and then swallow.
• Precautions: Do not eat, drink, or rinse the mouth for at least $30\text{ minutes}$ post-administration to maintain drug contact time with the oral mucosa; complete the full prescribed course.

Fluconazole: Precautions with Antifungals

Safety precautions and drug interactions for this azole antifungal:

• Contraindications: Contraindicated in severe renal or hepatic disease and azole hypersensitivity; Pregnancy Category C (use caution in pregnancy).
• Drug Interactions: Significantly elevates prothrombin time ($\text{PT/INR}$) with warfarin (bleeding risk); increases hypoglycemia when taken with oral sulfonylureas; carries a dangerous risk of fatal cardiac arrhythmias when combined with macrolides (erythromycin).

Metronidazole (Flagyl): Rationale to Confirm Diagnosis

Diagnostic necessity and safety considerations for this synthetic antimicrobial:

• Diagnostic Confirmation: Metronidazole acts specifically against obligate anaerobic bacteria and protozoans (e.g., amebiasis, trichomoniasis, bacterial vaginosis, $\textit{C. difficile}$); precise diagnosis confirmation is necessary to ensure drug efficacy and prevent resistance.
• Key Precautions: Complete avoidance of alcohol and alcohol-containing products during therapy and for $48\text{ hours}$ post-treatment to prevent severe disulfiram-like reactions; store protected from light in a foil bag.

Vancomycin: Red Man Syndrome Etiology

Pathophysiology and clinical management of this adverse infusion reaction:

• Etiology: A toxic, non-allergic infusion reaction triggered by rapid intravenous administration of vancomycin, prompting non-IgE-mediated histamine release (not an allergic reaction).
• Presentation: Severe hypotension, tachycardia, paresthesia, and prominent erythematous flushing of the face, neck, and upper chest.
• Management: Prevented by diluting the dose adequately ($100\,\text{mL}$ per $500\,\text{mg}$ or $200\,\text{mL}$ per $1\,\text{g}$) and infusing slowly at a rate $\le 10\,\text{mg/min}$ over a minimum of $60\text{ minutes}$.

Antiretroviral Therapy (HAART) Goals

The five core clinical objectives of combination antiretroviral therapy for HIV:

1. Reduce HIV-associated morbidity and prolong life duration.
2. Preserve and restore immune function ($\text{CD4}^+\text{ T}$ lymphocyte counts).
3. Maximally and durably suppress plasma HIV viral load.
4. Improve overall quality of life.
5. Prevent HIV transmission.

Post-Exposure Prophylaxis (PEP): Patient Education

Essential educational guidelines for post-HIV exposure protocols:

• Regimen & Timing: Emergency $2\text{-drug}$ antiretroviral regimen initiated within hours of exposure (ideally within $72\text{ hours}$) and maintained for $4\text{ weeks}$.
• Transmission Risk Context: Risk is approximately $0.3\%$ for percutaneous needle stick and $0.09\%$ for mucous membrane exposure.
• Patient Education: Emphasize strict adherence; educate on common side effects (nausea, fatigue, malaise); require scheduled follow-up HIV antibody testing.

Pre-Exposure Prophylaxis (PrEP): Indications and Contraindications

Clinical parameters for preventative antiretroviral regimens:

• Indications: Daily oral pill or long-acting monthly/bimonthly injection for HIV-negative individuals at substantial risk of HIV acquisition through high-risk sexual practices or injection drug use.
• Contraindications: Being HIV-positive is an absolute contraindication (using PrEP monotherapy with established HIV promotes drug-resistant viral strains).
• Testing Requirements: Documented negative HIV antibody testing prior to initiation and every $3\text{ months}$ thereafter; monitor liver and kidney function periodically.

Therapeutic vs. Prophylactic vs. Empiric Therapy

Differentiating antibacterial therapy classifications:

• Empiric Therapy: Administration of a broad-spectrum antibiotic initiated before a definitive pathogen diagnosis is established or culture results are back.
• Prophylactic Therapy: Preventative medication given prior to potential exposure (e.g., prior to dental procedures, colorectal/cardiac surgeries, or for latent TB) to ward off anticipated infection.
• Therapeutic Therapy: Targeted treatment chosen specifically against a known, identified pathogen following the finalization of culture and sensitivity ($\text{C\&S}$) results.

Pharmacokinetics, Pharmacodynamics, Safety, and Pregnancy Categories

Fundamental pharmacological principles and safety metrics:

• Pharmacokinetics vs. Pharmacodynamics: Pharmacokinetics describes what the body does to the drug ($\text{ADME}$; only unbound/free drug is active); pharmacodynamics describes what the drug does to the body.
• Pregnancy Categories: Category A (proven human safety); Category B (safe in pregnancy, e.g., penicillins, cephalosporins, acyclovir); Category C (fetal risk not ruled out, e.g., INH, fluconazole, zidovudine, gentamicin, fluoroquinolones); Category X/Contraindicated (teratogenic, e.g., tetracyclines cause permanent tooth discoloration).
• Safety Practices: Verify two client identifiers, verify allergies, manage high-alert drugs (insulin, heparin, narcotics), and document in real time.

IM and SC Injection Angles of Insertion

Standard insertion angles for parenteral injections:

• Intramuscular ($\text{IM}$): Insert perpendicular at a $90^\circ$ angle directly into muscle tissue (preferred sites: ventrogluteal or deltoid in adults; vastus lateralis in infants).
• Subcutaneous ($\text{SC}$): Insert at a $90^\circ$ angle (or $45^\circ$ for pediatric clients or individuals with minimal subcutaneous adipose tissue) into fatty connective tissue.
• (Intradermal injection: inserted at a shallow $10\text{--}15^\circ$ angle using a $1\,\text{mL}$ syringe to form a cutaneous wheal/bleb).

Antibiotics Used for Surgical Prophylaxis

The two primary antimicrobial agents highlighted for preventative surgical regimens:

• Cefazolin: A first-generation cephalosporin utilized for general and surgical prophylaxis (e.g., skin, bone, joint, and genital surgeries).
• Metronidazole (Flagyl): An antimicrobial agent active against anaerobes, specifically administered as prophylaxis for colorectal and bowel surgery.